Liraglutide vs. lixisenatide in obese type 2 diabetes mellitus patients: What effect should we expect in routine clinical practice?

Moreno-Fernandez Jesus; Alberto Garcia-Seco Jose; Seco Segura Angela Maria; Garcia-Seco Fernando; Rozas Moreno Pedro Jesus; Aguirre Sanchez-Covisa Miguel

首页> 外文期刊>Primary care diabetes >Liraglutide vs. lixisenatide in obese type 2 diabetes mellitus patients: What effect should we expect in routine clinical practice?

【24h】

Liraglutide vs. lixisenatide in obese type 2 diabetes mellitus patients: What effect should we expect in routine clinical practice?

机译：Liraglutide对肥胖型2型糖尿病患者的Lixisenatide：我们应该在常规临床实践中预期什么效果？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aim: Liraglutide and lixisenatide improved glycemic control, weight and cardiovascular risk factors (CVRF) in type 2 diabetes mellitus (T2DM) patients. Our objective was to analyze clinical efficacy and safety differences in routine clinical practice.

机译：目的：Liraglutide和Lixisenatide改善2型糖尿病（T2DM）患者的血糖控制，体重和心血管危险因素（CVRF）。我们的目标是分析常规临床实践中的临床疗效和安全差异。

著录项

来源
《Primary care diabetes》 |2020年第1期|共7页
作者
Moreno-Fernandez Jesus; Alberto Garcia-Seco Jose; Seco Segura Angela Maria; Garcia-Seco Fernando; Rozas Moreno Pedro Jesus; Aguirre Sanchez-Covisa Miguel;
展开▼
作者单位

Ciudad Real Gen Univ Hosp Endocrinol &

Nutr Dept C Obispo Rafael Torija S-N Ciudad Real 13005;

Ciudad Real Gen Univ Hosp Endocrinol &

Nutr Dept C Obispo Rafael Torija S-N Ciudad Real 13005;

Ciudad Real Gen Univ Hosp Endocrinol &

Nutr Dept C Obispo Rafael Torija S-N Ciudad Real 13005;

Cordoba Univ Avd Medina Azahara 5 Cordoba 14071 Spain;

Ciudad Real Gen Univ Hosp Endocrinol &

Nutr Dept C Obispo Rafael Torija S-N Ciudad Real 13005;

Ciudad Real Gen Univ Hosp Endocrinol &

Nutr Dept C Obispo Rafael Torija S-N Ciudad Real 13005;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词
Liraglutide; Lixisenatide; GLP-1 receptor agonists; Type 2 diabetes mellitus; Obesity; Routine clinical practice;

机译：Lixisenatide;Glp-1受体激动剂;2型糖尿病;肥胖;常规临床实践;

相似文献

外文文献
中文文献
专利

1. Liraglutide vs. lixisenatide in obese type 2 diabetes mellitus patients: What effect should we expect in routine clinical practice? [J] . Moreno-Fernandez Jesus, Alberto Garcia-Seco Jose, Seco Segura Angela Maria, Primary care diabetes . 2020,第1期

机译：Liraglutide对肥胖型2型糖尿病患者的Lixisenatide：我们应该在常规临床实践中预期什么效果？
2. COST-EFFECTIVENESS ANALYSIS OF LIRAGLUTIDE 1.8MG VERSUS LIXISENATIDE 20 mu G FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS IN ITALY [J] . Kragh N., Ye E., Valentine W. J., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：意大利2型糖尿病患者利拉格雷肽1.8毫克对20克利西塞那肽的成本效益分析
3. EVALUATING THE COST-EFFECTIVENESS OF LIRAGLUTIDE 1.8MG VERSUS LIXISENATIDE 20 mu G FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS IN THE UK SETTING [J] . Kragh N., Ye E., Hunt B., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：在英国，评估利拉糖肽1.8毫克与利塞塞那肽20微克在2型糖尿病患者中的成本效益
4. ACE gene I/D polymorphism and obesity in patients with type 2 diabetes mellitus [C] . Sounira Mehri, Mohamed Hammami International Conference on Engineering MIS . 2017

机译：2型糖尿病患者ACE基因I / D多态性与肥胖
5. Recruitment, retention and compliance in randomized, phase III clinical trials involving obese patients diagnosed with type 2 Diabetes Mellitus with respect to weight loss practicum report. [D] . Mithani, Moez S. 2012

机译：涉及诊断为2型糖尿病的肥胖患者的有关减肥实践的随机III期临床试验中的招募，保留和依从性报告。
6. Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice—EVIDENCE: A Prospective 2-Year Follow-Up Observational Post-Marketing Study [O] . Jean-Francois Gautier, Luc Martinez, Alfred Penfornis, -1

机译：常规临床实践中的2型糖尿病患者使用利拉鲁肽的有效性和持续性-证据：一项为期2年的随访观察上市后研究
7. Liraglutide effect and action in diabetes-In (LEAD-In): A prospective observational study assessing safety and effectiveness of liraglutide in patients with type 2 diabetes mellitus treated under routine clinical practice conditions in India [O] . Subhash Kumar Wangnoo, Surender Kumar, Arpandev Bhattacharyya, 2016

机译：利拉鲁肽在糖尿病中的作用和作用-LE（LEaD-In）：一项前瞻性观察性研究，评估利拉鲁肽在印度常规临床实践条件下治疗的2型糖尿病患者的安全性和有效性

Liraglutide vs. lixisenatide in obese type 2 diabetes mellitus patients: What effect should we expect in routine clinical practice?

摘要

著录项

相似文献

相关主题

期刊订阅